Abbott Pharma Limited
About Abbott Pharma Limited
Data last updated:
Abbott Pharma Limited is a public limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 24 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PLC177143.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Pankaj Kumar Jha and Man Mohan Sharma.
Its last annual general meeting (AGM) was held on 31 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 201 02nd Floor Mohan Place Lsc, Block – C Saraswati Vihar, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹47,899, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹1,337 (net margin -2.8%) and EBITDA of -₹978 (EBITDA margin -2%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Abbott Pharma Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address201 02nd Floor Mohan Place Lsc, Block – C Saraswati Vihar, Delhi, India – 110034
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Abbott Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Abbott Pharma Limited
FY 2026 filings availableAbbott Pharma Limited reported revenue of ₹47,899 (up 2% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 26%. EBITDA fell 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹47,899 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹978 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,337 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abbott Pharma Limited, buy the company report.
Board of directors of Abbott Pharma Limited
Abbott Pharma has 3 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Kumar Jha | Director | 08 Jun 2018 | 8 Years 5 Months | Current |
| Man Mohan Sharma Also directs: Dhanwantri Vedaresearch LLP, Delcure Lifesciences Limited | Director | 08 Apr 2023 | 3 Years 7 Months | Current |
| Neetika Goel Also directs: Parke Davis Healthcare Limited, Plenteous Pharmaceuticals Limited, Nicholas Healthcare Limited and 1 more | Director | 08 Nov 2024 | 2 Years 0 Months | Current |
Auditor
Abbott Pharma Limited is audited by V.P. GUPTA & CO. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.P. GUPTA & CO. | FY 2026 | 000699N |
Shareholding
The shareholding of Abbott Pharma Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Abbott Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Abbott Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abbott Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Abbott Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Abbott Pharma Limited has 17 board changes on record since 2009: 3 appointments and 14 cessations. The latest: Neetika Goel ceased to be Additional Director on 10 May 2025.
8 earlier events are in the company report.
Frequently asked questions
Abbott Pharma is an active public limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 24 April 2008 (18+ years old) and is registered under CIN U24232DL2008PLC177143.
Abbott Pharma has 3 current directors:
- Pankaj Kumar Jha - Director
- Man Mohan Sharma - Director
- Neetika Goel - Director
The latest financial statements of Abbott Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 May 2026. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Abbott Pharma is U24232DL2008PLC177143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abbott Pharma was incorporated on 24 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Neetika Goel ceased to be Additional Director on 10 May 2025. Neetika Goel was appointed as Director on 08 Nov 2024. Kusum Pal Sharma ceased to be Additional Director on 03 May 2024. Abbott Pharma has 17 board changes on record in total.
The registered office of Abbott Pharma is at 201 02nd Floor Mohan Place Lsc, Block – C Saraswati Vihar, Delhi, India – 110034.
Abbott Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.
The compliance status of Abbott Pharma is compliant as of 01 November 2026. The company is actively filing with the Registrar of Companies.
Abbott Pharma can be reached at its registered office: 201 02nd Floor Mohan Place Lsc, Block – C Saraswati Vihar, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
